Sichenzia Ross Ference LLP Represents H.C. Wainwright in $6 Million At-The-Market Offering of Sonoma Pharmaceuticals, Inc.
Press Release – New York, NY – August 2, 2021 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sales agent in a $6 million At-The-Market Offering (“ATM”) of Sonoma Pharmaceuticals, Inc. (NASDAQ: “SNOA”) common stock.
The shares were registered on SNOA’s registration statement on Form S-3 (File No. 333-250925), which was declared effective by the SEC on December 22, 2020, and prospectus supplement relating to the ATM filed with the Securities and Exchange Commission on July 30, 2021.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, Avital Perlman and Jeff Cahlon and associates Matthew Siracusa and Mayank Pradhan.
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp.in $1.7 Million At-The-Market Offering Facility with SciSparc Ltd. - May 24, 2023
- Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $5.0 Million Private Placement Priced At-the-Market - May 16, 2023
- Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2.0 Million Public Offering - May 15, 2023